Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in J Pediatr Hematol Oncol Retrieve available abstracts of 160 articles: HTML format

Single Articles

October 2023
1. KARAHAN F, Yilmaz SS, Bayrakdar F, Tezol O, et al
   Evaluation of Intestinal Microbiota in Children With Sickle Cell Disease.
   J Pediatr Hematol Oncol. 2023;45:e904-e909.
   PubMed     Abstract available
   
   
   August 2023
2. GALADANCI AA, Estepp JH, Khan H, Farouk ZL, et al
   Barriers and Facilitators of Premarital Genetic Counseling for Sickle Cell Disease in Northern Nigeria.
   J Pediatr Hematol Oncol. 2023;45:e716-e722.
   PubMed     Abstract available
   
   
   
3. NOORDSTAR JJ, Hulzebos EHJ, van der Ent CK, Suijker MH, et al
   Organized Sports Activities Are Safe for Children With Sickle Cell Disease: A Pilot Intervention Study.
   J Pediatr Hematol Oncol. 2023;45:e710-e715.
   PubMed     Abstract available
   
   
   
4. PUGH C, Zeno RN, Stanek J, Gillespie M, et al
   Description of a Colocated Comprehensive Care Model for People With Sickle Cell and Comorbid Pulmonary Disease.
   J Pediatr Hematol Oncol. 2023;45:e723-e727.
   PubMed     Abstract available
   
   
   July 2023
5. RESTIVO GA, Scalzo S, Di Palermo A
   Mechanical Hemolytic Anemia Associated With Mitral Valve Repair: A Case Report With Literature Review.
   J Pediatr Hematol Oncol. 2023 Jul 26. doi: 10.1097/MPH.0000000000002734.
   PubMed     Abstract available
   
   
   
6. YAN A, Tole S, Bair L, Wagner A, et al
   Reassessing the Need for Preoperative Transfusions in Sickle Cell Disease Patients With an Elevated Baseline Hemoglobin-A Retrospective Study.
   J Pediatr Hematol Oncol. 2023;45:241-246.
   PubMed     Abstract available
   
   
   May 2023
7. PAULUKONIS ST, Snyder A, Smeltzer MP, Sutaria AN, et al
   COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
   J Pediatr Hematol Oncol. 2023;45:174-180.
   PubMed     Abstract available
   
   
   
8. ILONZE C, Anderson M, Stubblefield A, McNall-Knapp R, et al
   Transforming Growth Factor Beta 1 as a Potential Biomarker in Children With Sickle Cell Disease.
   J Pediatr Hematol Oncol. 2023;45:225-226.
   PubMed    
   
   
   
9. KOSKELA-STAPLES NC, Evans C, Turner EM, Black LV, et al
   The Association Between Caregiver Coping and Youth Clinic Attendance and Health-related Quality of Life in Pediatric Sickle Cell Disease.
   J Pediatr Hematol Oncol. 2023;45:e433-e440.
   PubMed     Abstract available
   
   
   April 2023
10. PATEL A, Winter T, Jain A
    A Rare Report of the Coexistence of Sickle Cell Disease, Neurofibromatosis Type 1, and Intracranial Hypertension in a Pediatric Patient.
    J Pediatr Hematol Oncol. 2023;45:155-158.
    PubMed     Abstract available
    
    
    
11. DUARTE M, Almeida Borges M, Kjollerstrom P, Maia R, et al
    Sickle Cell Disease Diagnosis Uncovered by Incidental Radiograph Findings.
    J Pediatr Hematol Oncol. 2023;45:151.
    PubMed    
    
    
    
12. DASDEMIR S, Kaya Z, Bento C
    Peripheral Blood Smear Findings in 2 Patients With Coexisting Thalassemia and Hereditary Spherocytosis.
    J Pediatr Hematol Oncol. 2023;45:149-150.
    PubMed    
    
    
    
13. AKCA T, Ozdemir GN, Aycicek A, Ozkaya G, et al
    Long-term Results of Splenectomy in Transfusion-dependent Thalassemia.
    J Pediatr Hematol Oncol. 2023;45:143-148.
    PubMed     Abstract available
    
    
    March 2023
14. YARNALL JN, Mertens A, Yee M, Orenstein E, et al
    Influenza Vaccination Receipt in Pediatric Patients With Cancer or Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e228-e235.
    PubMed     Abstract available
    
    
    
15. CALDERWOOD S, Sabir A, Rao L, Baker B, et al
    SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2023;45:82-87.
    PubMed     Abstract available
    
    
    February 2023
16. IMASHUKU S, Suemori SI, Wakamatsu M, Okuno Y, et al
    Juvenile Hemochromatosis With Non-transfused Hemolytic Anemia Caused by a De Novo PIEZO1 Gene Mutation.
    J Pediatr Hematol Oncol. 2023 Feb 21. doi: 10.1097/MPH.0000000000002639.
    PubMed     Abstract available
    
    
    
17. FARRIS N, Benoit SW, McNinch NL, Bodas P, et al
    Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises.
    J Pediatr Hematol Oncol. 2023 Feb 20. doi: 10.1097/MPH.0000000000002642.
    PubMed     Abstract available
    
    
    January 2023
18. ABDULLA AM, Frances A, Helou M
    Utility of Whole Exome Sequencing in the Early Diagnosis of Atypical Diamond-Blackfan Anemia.
    J Pediatr Hematol Oncol. 2023 Jan 9. doi: 10.1097/MPH.0000000000002616.
    PubMed     Abstract available
    
    
    
19. UDOMPONGLUKKANA R, Sasanakul W, Tangbubpha N, Chuansumrit A, et al
    Response to Prolonged Duration of Therapeutic Dose Oral Iron Therapy in a Girl With Novel TMPRSS6 Gene Variants: A Case Report and Review Literature.
    J Pediatr Hematol Oncol. 2023;45:e109-e118.
    PubMed     Abstract available
    
    
    
20. WU HW, Gannon M, Hsu LL
    Evaluation of Glutamine Utilization in Patients With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e52-e55.
    PubMed     Abstract available
    
    
    
21. ELHAWARY EE, Khedr SF, Nagy HM, El-Bradey MH, et al
    Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e48-e51.
    PubMed     Abstract available
    
    
    
22. MACK JM, Frankowski S, Verkamp B, Crary SE, et al
    Pupil Size and Reactivity in Pediatric Patients With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e44-e47.
    PubMed     Abstract available
    
    
    November 2022
23. LEE AJ, Leonard A, Markham KB
    Fetal and Neonatal Reticulocyte Count Response to Intrauterine Transfusion for the Treatment of Red Blood Cell Alloimmunization.
    J Pediatr Hematol Oncol. 2022;44:e1046-e1049.
    PubMed     Abstract available
    
    
    October 2022
24. SHAH NR, Treadwell MJ, Vichinsky E
    Transitioning Adolescents With Sickle Cell Disease From Pediatric to Adult Care: Results From a New Survey of Health Care Professionals.
    J Pediatr Hematol Oncol. 2022;44:e999-e1005.
    PubMed     Abstract available
    
    
    
25. PAUL-HANNA M, Joseph W, Mondesir W, Faustino EVS, et al
    Introduction of Hydroxyurea Therapy to a Cohort of Sickle Cell Patients in Northern Haiti.
    J Pediatr Hematol Oncol. 2022;44:351-353.
    PubMed     Abstract available
    
    
    
26. ZAHR RS, Ding J, Kang G, Wang WC, et al
    Enuresis and Hyperfiltration in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2022;44:358-362.
    PubMed     Abstract available
    
    
    September 2022
27. ORHAN MF, Buyukavci M
    Intravenous Iron Therapy for Children With Iron Deficiency Anemia.
    J Pediatr Hematol Oncol. 2022 Sep 14. pii: 00043426-990000000-00095.
    PubMed     Abstract available
    
    
    
28. GRUDA SUSSMAN R, Yan AP, Baker JM
    Glucose 6 Phosphate Isomerase Deficiency, a Rare Hemolytic Anemia Misdiagnosed as Hereditary Spherocytosis.
    J Pediatr Hematol Oncol. 2022 Sep 12. pii: 00043426-990000000-00091.
    PubMed     Abstract available
    
    
    August 2022
29. ISMAIL AM, Mahmoud NMS, Ghazawy ER, Mousa SO, et al
    Prevalence of COVID-19 in Egyptian Children With Hemoglobinopathies and Inherited Anemias.
    J Pediatr Hematol Oncol. 2022;44:e954-e959.
    PubMed     Abstract available
    
    
    July 2022
30. TAS N, Gokceoglu AU, Yayla BCC, Ozcan A, et al
    Hemophagocytic Lymphohistiocytosis Associated With Hemolytic Uremic Syndrome in a Child: A Case Report and Systematic Literature Review.
    J Pediatr Hematol Oncol. 2022;44:e905-e910.
    PubMed     Abstract available
    
    
    
31. CALHOUN C, Luo L, Baumann AA, Bauer A, et al
    Transition for Adolescents and Young Adults With Sickle Cell Disease in a US Midwest Urban Center: A Multilevel Perspective on Barriers, Facilitators, and Future Directions.
    J Pediatr Hematol Oncol. 2022;44:e872-e880.
    PubMed     Abstract available
    
    
    
32. BOSCH A, Watad S, Willmott S, McKinnon NK, et al
    Identifying and Treating Severe Bone Marrow Necrosis and Fat Embolism Syndrome in Pediatric Patients With Sickle Cell Disease: A Case Report.
    J Pediatr Hematol Oncol. 2022;44:e884-e887.
    PubMed     Abstract available
    
    
    
33. DOSHI BS, Kamdar A, Lambert MP, Obstfeld AE, et al
    Hemolysis After Medication Exposure in Pediatric Patients With G6PD Deficiency.
    J Pediatr Hematol Oncol. 2022;44:261-263.
    PubMed     Abstract available
    
    
    
34. GALADANCI NA, Sohail M, Akinyelure OP, Kanter J, et al
    Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort.
    J Pediatr Hematol Oncol. 2022;44:249-254.
    PubMed     Abstract available
    
    
    
35. EL-BESHLAWY A, Abdel-Azim K, Abdel-Salam A, Gebril NA, et al
    Clinical Characteristics, Molecular Background, and Survival of Egyptian Patients With Gaucher Disease Over a 20-Year Follow-up.
    J Pediatr Hematol Oncol. 2022;44:243-248.
    PubMed     Abstract available
    
    
    May 2022
36. 
    Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework: Erratum.
    J Pediatr Hematol Oncol. 2022;44:193.
    PubMed    
    
    
    
37. ALVAREZ O, Cumming V, Fifi AC
    Assessment of Liver Fibrosis by Transient Elastography in Children and Young Adults With Sickle Cell Disease With and Without Iron Overload.
    J Pediatr Hematol Oncol. 2022;44:155-158.
    PubMed     Abstract available
    
    
    
38. EL-BESHLAWY A, Rabah F, Hamed HM, Mahmoud AA, et al
    Navigating Hemostasis of Bleeding Among Children With beta-Thalassemia.
    J Pediatr Hematol Oncol. 2022;44:e855-e858.
    PubMed     Abstract available
    
    
    April 2022
39. REAL FJ, Hood AM, Davis D, Cruse B, et al
    An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia.
    J Pediatr Hematol Oncol. 2022;44:e799-e803.
    PubMed     Abstract available
    
    
    
40. KWARTENG-SIAW M, Benneh-Akwasi Kuma A, Green NS
    Transition Preparation and Satisfaction of Care Among Adolescents and Young Adults With Sickle Cell Disease at the Ghana Institute of Clinical Genetics.
    J Pediatr Hematol Oncol. 2022;44:e682-e688.
    PubMed     Abstract available
    
    
    
41. CARLL TC, Mariani R, Schafernak K, Snowberger T, et al
    Peripheral Blood Smear Detection of Asymptomatic Central Line Infection in a Patient With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2022;44:98-99.
    PubMed     Abstract available
    
    
    
42. TOWERMAN AS, Reich PJ, Hulbert ML
    A Case Series of Kawasaki Disease in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2022;44:103-105.
    PubMed     Abstract available
    
    
    March 2022
43. FLORES ORIA CA, Stark JM, Mosquera RA, Brown DL, et al
    Sleep Apnea Screening in Children With Sickle Cell Anemia.
    J Pediatr Hematol Oncol. 2022 Mar 31. pii: 00043426-990000000-00003.
    PubMed     Abstract available
    
    
    
44. BLACKALL D, Dolatshahi L
    Autoimmune Hemolytic Anemia in Children: Laboratory Investigation, Disease Associations, and Treatment Strategies.
    J Pediatr Hematol Oncol. 2022 Mar 1. pii: 00043426-900000000-96645.
    PubMed     Abstract available
    
    
    
45. WU HW, Rahim N, Mbadiwe N, Khayat S, et al
    Vaso-occlusive Pain Crisis Mimicking Mandibular Abscess in an Adolescent with Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2022;44:e450-e452.
    PubMed     Abstract available
    
    
    
46. CLEMENT O, Fishbein J, Appiah-Kubi A, Aygun B, et al
    Documented Viral Illness at the Time of Splenic Sequestration Does Not Affect the Odds of Recurrence in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2022;44:40-42.
    PubMed     Abstract available
    
    
    
47. RADHAKRISHNAN K, Downie PA, Earley CM
    Paroxysmal Cold Hemoglobinuria: Diagnosis From the Blood Smear.
    J Pediatr Hematol Oncol. 2022;44:60-61.
    PubMed     Abstract available
    
    
    
48. DAWSON A, Mullen K, Janson IA, Henriksen B, et al
    A Feasibility Pilot Study of Online Modules of Hydroxyurea and Sickle Cell Disease Care for Adolescents and Young Adults for Family Medicine Residents.
    J Pediatr Hematol Oncol. 2022;44:e313-e318.
    PubMed     Abstract available
    
    
    
49. BAKER KM, Parikh NS, Salsbery KT, Shaw GR, et al
    A 17-Month-old Boy With Pancytopenia Caused by a Rare Genetic Defect of Vitamin B12 Malabsorption.
    J Pediatr Hematol Oncol. 2022;44:e444-e446.
    PubMed     Abstract available
    
    
    
50. KILIC MA, Ozdemir GN, Tahtakesen TN, Gokce M, et al
    Clinical Features and Outcome of Children With Hereditary Spherocytosis.
    J Pediatr Hematol Oncol. 2022;44:e306-e309.
    PubMed     Abstract available
    
    
    
51. BHASIN N, Price N, Desoky SM
    Multifocal Osteonecrosis in a 3-Year-old Child With Sickle Beta Plus Thalassemia.
    J Pediatr Hematol Oncol. 2022;44:e428-e430.
    PubMed     Abstract available
    
    
    
52. GRACIAA SH, Graciaa DS, Yildirim I, Chonat S, et al
    Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade.
    J Pediatr Hematol Oncol. 2022;44:e493-e495.
    PubMed     Abstract available
    
    
    February 2022
53. MAHAJAN RG, Mosainder Joyce H, Green N, Hijiya N, et al
    Rare Presentation of Atypical Hemolytic Uremic Syndrome in a Child With Acute Lymphocytic Leukemia and Pancreatitis.
    J Pediatr Hematol Oncol. 2022 Feb 18. pii: 00043426-900000000-96652.
    PubMed     Abstract available
    
    
    January 2022
54. ESPANOL MG, Gardner RV, Alicea-Marrero MM, Marrero-Rivera G, et al
    Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report.
    J Pediatr Hematol Oncol. 2022;44:e134-e137.
    PubMed     Abstract available
    
    
    
55. KUPESIZ FT, Sivrice C, Akinel A, Kintrup GT, et al
    Efficacy and Safety of Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Thalassemia Patients: A Retrospective Observational Study.
    J Pediatr Hematol Oncol. 2022;44:e26-e34.
    PubMed     Abstract available
    
    
    
56. GOLDBERG EK, Lal A, Fung EB
    Nutrition in Thalassemia: A Systematic Review of Deficiency, Relations to Morbidity, and Supplementation Recommendations.
    J Pediatr Hematol Oncol. 2022;44:1-11.
    PubMed     Abstract available
    
    
    
57. YU H, Chen A, Chen E, Long LS, et al
    Low-dose Ketamine Infusion for Pediatric Hematology/Oncology Patients: Case Series and Literature Review.
    J Pediatr Hematol Oncol. 2022;44:e188-e193.
    PubMed     Abstract available
    
    
    
58. HAMDY M, Shaheen I, Seif El Din H, Ali B, et al
    Klotho Level as a Marker of Low Bone Mineral Density in Egyptian Sickle Cell Disease Patients.
    J Pediatr Hematol Oncol. 2022;44:e40-e45.
    PubMed     Abstract available
    
    
    
59. GHAFURI DL, Abdullahi SU, Dambatta AH, Galadanci J, et al
    Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
    J Pediatr Hematol Oncol. 2022;44:e56-e61.
    PubMed     Abstract available
    
    
    
60. RAHIM MQ, Arends AM, Jacob SA
    Maintenance of an Immunogenic Response to Pneumococcal Vaccination in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2022;44:e51-e55.
    PubMed     Abstract available
    
    
    
61. LO ZC, Sobota AE
    Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic.
    J Pediatr Hematol Oncol. 2022;44:e46-e50.
    PubMed     Abstract available
    
    
    
62. ANSARI SH, Hussain Z, Zohaib M, Parveen S, et al
    A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among beta-Thalassemia Major Patients in Pakistan.
    J Pediatr Hematol Oncol. 2022;44:e77-e83.
    PubMed     Abstract available
    
    
    December 2021
63. NISHIKADO M, Awaguni H, Shinozuka J, Okumura K, et al
    Puzzling (IRIDA-Like and Hemolytic) Anemia in a Child With Idiopathic Pulmonary Hemosiderosis.
    J Pediatr Hematol Oncol. 2021 Dec 30. pii: 00043426-900000000-96695.
    PubMed     Abstract available
    
    
    
64. BOYADJIAN M, Follenfant E, Chamouine A, Maillard O, et al
    Acute Hemolytic Anemia Caused by G6PD Deficiency in Children in Mayotte: A Frequent and Severe Complication.
    J Pediatr Hematol Oncol. 2021 Dec 30. pii: 00043426-900000000-96692.
    PubMed     Abstract available
    
    
    
65. KOTWAL N, Pillai DK, Darbari DS, Sun K, et al
    Spirometric Changes After Initiation of Hydroxyurea in Children With Sickle Cell Anemia.
    J Pediatr Hematol Oncol. 2021 Dec 30. pii: 00043426-900000000-96691.
    PubMed     Abstract available
    
    
    
66. ZHENG F, Jia Y, Zhang L, Qin J, et al
    Hemophagocytic Lymphohistiocytosis Secondary to Juvenile Myelomonocytic Leukemia: A Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2021 Dec 3. pii: 00043426-900000000-96716.
    PubMed     Abstract available
    
    
    November 2021
67. OYMAK Y, Karapinar TH
    COVID-19 Pandemic and Thalassemia Major Patients: Transfusion Practice and Treatment Assessment.
    J Pediatr Hematol Oncol. 2021;43:e1073-e1076.
    PubMed     Abstract available
    
    
    
68. HALYKO M, Thompson K, Ruiz JP, Scott JP, et al
    Pulmonary Blastomycosis: A Rare Cause of Acute Chest Syndrome and Prolonged Fevers in a Pediatric Patient With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:e1235-e1237.
    PubMed     Abstract available
    
    
    
69. SCHWORER SA, Francis OL, Johnson SM, Smith BD, et al
    Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review.
    J Pediatr Hematol Oncol. 2021;43:281-287.
    PubMed     Abstract available
    
    
    
70. HAMDY M, Shaheen I, El-Gammal ZM, Ramadan YM, et al
    Detection of Renal Insufficiency in a Cohort of Patients With Beta-thalassemia Major Using Cystatin-C.
    J Pediatr Hematol Oncol. 2021;43:e1082-e1087.
    PubMed     Abstract available
    
    
    
71. CERVERA BRAVO A, Osuna Marco MP, Moran-Jimenez MJ, Martin-Hernandez E, et al
    Unexpected Cause of Persistent Microcytosis and Neurological Symptoms in a Child: Niemann-Pick Disease Type C.
    J Pediatr Hematol Oncol. 2021;43:e1238-e1240.
    PubMed     Abstract available
    
    
    
72. OM A, Mathew N, Nawaz A
    Quality and Reliability of YouTube Videos on Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:e1247-e1248.
    PubMed    
    
    
    
73. ZANETTI RC, Vasta LM, Romanelli K, Newton TC, et al
    Management of Hyperhemolysis in beta-thalassemia With Multiple Immunosuppressives, Including Complement Blockade.
    J Pediatr Hematol Oncol. 2021;43:e1145-e1147.
    PubMed     Abstract available
    
    
    
74. POMONI A, Aggeli I, Loutsi E, Hatzimichael E, et al
    Cyanosis Due to Methemoglobinemia as the Presenting Sign of Glucose-6-Phosphate Dehydrogenase Deficiency in a Child: Diagnostic and Clinical Implications.
    J Pediatr Hematol Oncol. 2021;43:e1140-e1144.
    PubMed     Abstract available
    
    
    October 2021
75. AL SABAHI A, Al Maskari N, Al Busaidi I, Albiroty KA, et al
    Coronavirus Disease 2019 Infection in Children With Sickle Cell Disease: Case Series From Oman.
    J Pediatr Hematol Oncol. 2021;43:e975-e978.
    PubMed     Abstract available
    
    
    
76. AYDIN S, Yeral H, Oktay G, Coban Y, et al
    Associations Between Transcranial Doppler Flow Velocities, Laboratory Parameters, and Clinical Features in Turkish Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:249-253.
    PubMed     Abstract available
    
    
    
77. CHAKRABORTY S, Sachdev M, Bansal M, Dua V, et al
    Pulmonary Toxicity From Granulocyte Colony Stimulating Factor in a Pediatric Patient Undergoing Autologous Stem Cell Harvest.
    J Pediatr Hematol Oncol. 2021;43:e1048-e1049.
    PubMed    
    
    
    
78. RETTENBACHER E, Zaal J, Heijboer H, van der Plas EM, et al
    Mortality and Causes of Death From Sickle Cell Disease in The Netherlands, 1985-2017.
    J Pediatr Hematol Oncol. 2021;43:258-265.
    PubMed     Abstract available
    
    
    
79. SPOORENBERG ME, Wachters-Hagedoorn RE, van Wijk R, de Kok JB, et al
    Infantile Pyknocytosis in a Premature Dichorionic Diamniotic Twin.
    J Pediatr Hematol Oncol. 2021;43:e1037-e1039.
    PubMed     Abstract available
    
    
    
80. WAISBOURD-ZINMAN O, Frenklak R, Hakakian O, Hilmara D, et al
    Autoimmune Liver Disease in Patients With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:254-257.
    PubMed     Abstract available
    
    
    September 2021
81. MADDILETI V, Gazula S, Dantala P
    An Unusual Presentation of Sacrococcygeal Germ Cell Tumor With Autoimmune Hemolytic Anemia as a Paraneoplastic Syndrome.
    J Pediatr Hematol Oncol. 2021 Sep 6. pii: 00043426-900000000-96775.
    PubMed     Abstract available
    
    
    
82. FUSTINO NJ, Waddell JP, Panzer ZR
    A 12-Year-Old Girl With Chronic Pediculosis Infestation Presenting With Severe Iron Deficiency Anemia.
    J Pediatr Hematol Oncol. 2021 Sep 6. pii: 00043426-900000000-96773.
    PubMed     Abstract available
    
    
    August 2021
83. TUFEKCI O, Ozdemir H, Malbora B, Ozbek NY, et al
    Hepatitis-Associated Aplastic Anemia: Etiology, Clinical Characteristics and Outcome.
    J Pediatr Hematol Oncol. 2021 Aug 13. pii: 00043426-900000000-96809.
    PubMed     Abstract available
    
    
    
84. BAGHERSALIMI A, Darbandi B, Kazemnezhad Leyli E, Kamran Mavardiani Z, et al
    Evaluation of Self-efficacy in Children and Adolescents With Thalassemia Major.
    J Pediatr Hematol Oncol. 2021;43:e754-e758.
    PubMed     Abstract available
    
    
    
85. ZHOU S, Dong X, Chen C, Ma L, et al
    Efficacy and Safety of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Review and Meta-Analysis.
    J Pediatr Hematol Oncol. 2021;43:203-210.
    PubMed     Abstract available
    
    
    
86. REMY A, Theoret Y, Ansari M, Bittencourt H, et al
    Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some Controls.
    J Pediatr Hematol Oncol. 2021;43:e867-e872.
    PubMed     Abstract available
    
    
    
87. PIRRONE I, Farruggia P, Cacciatore F, Giambona A, et al
    Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review.
    J Pediatr Hematol Oncol. 2021;43:e886-e890.
    PubMed     Abstract available
    
    
    July 2021
88. URATA T, Imamura T, Osone S, Muramatsu H, et al
    Genetic Study of Fanconi Anemia in Infancy Revealed FANCI Mutations and Defective ALDH2 Variant: A Case Report.
    J Pediatr Hematol Oncol. 2021 Jul 23. pii: 00043426-900000000-96821.
    PubMed     Abstract available
    
    
    
89. OZTURK Z, Gumuslu S, Yalcin K, Kupesiz A, et al
    Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.
    J Pediatr Hematol Oncol. 2021;43:186-192.
    PubMed     Abstract available
    
    
    
90. DE A, Anekwe CV, Kattan M, Yao Y, et al
    Validation of a Questionnaire to Identify Respiratory Tract Infections in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:e661-e665.
    PubMed     Abstract available
    
    
    
91. CONNOLLY ME, Bills SE, Hardy SJ
    Cognitive Functioning and Educational Support Plans in Youth With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:e666-e676.
    PubMed     Abstract available
    
    
    
92. ARIKAN K, Aytac S, Buyukcam A, Cengiz AB, et al
    Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
    J Pediatr Hematol Oncol. 2021;43:e613-e618.
    PubMed     Abstract available
    
    
    
93. ORDONEZ J, Del Canizo A, Belendez C, Garcia-Morin M, et al
    Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia Major.
    J Pediatr Hematol Oncol. 2021;43:e655-e660.
    PubMed     Abstract available
    
    
    
94. VISSING A, Wautlet A, Jain S
    An Atypical Case of Thrombotic Microangiopathy Secondary to Acute Pancreatitis.
    J Pediatr Hematol Oncol. 2021;43:e736-e738.
    PubMed     Abstract available
    
    
    May 2021
95. ADENIYI AT, Okeniyi JAO, Adegoke SA, Oseni SBA, et al
    Clinical Utilities of Electrocardiography in the Diagnosis of Myocardial Ischemia in Children With Sickle Cell Anemia: Correlation With Serum Cardiac Troponin I.
    J Pediatr Hematol Oncol. 2021 May 31. pii: 00043426-900000000-96859.
    PubMed     Abstract available
    
    
    
96. RINEHARDT HN, Villella AD, Milanes-Yearsley M, Kelly S, et al
    Successful Liver Transplantation for Adolescent Patient With Pyruvate Kinase Deficiency-induced Cirrhosis.
    J Pediatr Hematol Oncol. 2021;43:e605-e607.
    PubMed     Abstract available
    
    
    
97. HENDERSON C, Lo M, Massey G
    Pediatric Paroxysmal Nocturnal Hemoglobinuria Presenting as Acute Kidney Injury.
    J Pediatr Hematol Oncol. 2021;43:e543-e545.
    PubMed     Abstract available
    
    
    
98. YU J, Black V, Lamba J, Horn B, et al
    Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2021;43:e583-e586.
    PubMed     Abstract available
    
    
    April 2021
99. TOPYILDIZ E, Edeer Karaca N, Bas I, Aykut A, et al
    A Novel Homozygous TRNT1 Mutation in a Child With an Early Diagnosis of Common Variable Immunodeficiency Leading to Mild Hypogammaglobulinemia and Hemolytic Anemia.
    J Pediatr Hematol Oncol. 2021 Apr 9. pii: 00043426-900000000-96923.
    PubMed     Abstract available
    
    
    
100. KNIGHT LMJ, King AA, Strouse JJ, Tanabe P, et al
     Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.
     J Pediatr Hematol Oncol. 2021;43:104-111.
     PubMed     Abstract available
     
     
     
101. NANDAKUMAL G, Ismail F, Mohamad NF, Lott PW, et al
     A Rare Case of von Willebrand Disease Presenting as Hemolacria and Literature Review.
     J Pediatr Hematol Oncol. 2021;43:101-103.
     PubMed     Abstract available
     
     
     
102. YAMSRI S, Kawon W, Duereh A, Fucharoen G, et al
     Southeast Asian Ovalocytosis and Hemoglobinopathies in Newborns: Prevalence, Molecular, and Hematologic Analyses.
     J Pediatr Hematol Oncol. 2021;43:e341-e345.
     PubMed     Abstract available
     
     
     
103. MURTAS A, Zanza C, Vacca N, Saderi L, et al
     Assessment of Bone Metabolism Alterations in Transfusion-dependent Beta-thalassemia Major: An Observational Study.
     J Pediatr Hematol Oncol. 2021;43:118-119.
     PubMed    
     
     
     
104. AL-HUNITI A, Rathi N, Modi A, Bhagavathi S, et al
     Up-front Treatment With Romiplostim in Children With Acquired Bone Marrow Failure: A Single Institutional Pediatric Case Series.
     J Pediatr Hematol Oncol. 2021;43:e431-e435.
     PubMed     Abstract available
     
     
     March 2021
105. OZDEMIR ZC, Duzenli Kar Y, Bor O
     Whole Blood miR-210, miR-122, miR-223 Expression Levels and Their Relationship With Iron Status Parameters and Hypercoagulobility Indices in Children With Iron Deficiency Anemia.
     J Pediatr Hematol Oncol. 2021 Mar 12. pii: 00043426-900000000-96945.
     PubMed     Abstract available
     
     
     
106. USTABAS KAHRAMAN F, Cakir FB, Buhur Pirimoglu M, Torun E, et al
     Association of Myeloperoxidase Gene Polymorphism With Iron Deficiency Anemia in Turkish Children.
     J Pediatr Hematol Oncol. 2021 Mar 3. pii: 00043426-900000000-96948.
     PubMed     Abstract available
     
     
     
107. 
     Congenital Anemia Phenotypes Due to KLF1 Mutations: Erratum.
     J Pediatr Hematol Oncol. 2021;43:78.
     PubMed    
     
     
     
108. MORALES S, Nael A, Buchbinder D
     Copper Deficiency and Cytopenias.
     J Pediatr Hematol Oncol. 2021;43:68-69.
     PubMed    
     
     
     
109. ABU-QUIDER A, Asleh M, Fruchtman Y, Ben-Harosh M, et al
     Factor VII Deficiency in Patients Receiving Chronic Packed Cell Transfusions.
     J Pediatr Hematol Oncol. 2021;43:e268-e271.
     PubMed     Abstract available
     
     
     
110. GOUDARZIPOUR K, Amiri V, Eshghi P
     Successful Splenectomy Management in a Patient With Moderate Factor VII Deficiency and Concomitant Severe Hereditary Spherocytosis.
     J Pediatr Hematol Oncol. 2021;43:e243-e245.
     PubMed     Abstract available
     
     
     
111. ROSA J, Arruda A, Rodrigues AL, Soares MR, et al
     Paroxysmal Nocturnal Hemoglobinuria: Case Report of a Rare Cause of Thrombosis in the Pediatric Age.
     J Pediatr Hematol Oncol. 2021;43:e240-e242.
     PubMed     Abstract available
     
     
     February 2021
112. KANTER J, Phillips S, Schlenz AM, Mueller M, et al
     Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study.
     J Pediatr Hematol Oncol. 2021 Feb 22. pii: 00043426-900000000-96986.
     PubMed     Abstract available
     
     
     
113. KACZOROWSKA-HAC B, Luszczyk M, Wasilewska E, Antosiewicz J, et al
     Erythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene.
     J Pediatr Hematol Oncol. 2021 Feb 22. pii: 00043426-900000000-96971.
     PubMed     Abstract available
     
     
     
114. JHAVERI S, Choueiter N, Manwani D, Ranabothu S, et al
     Association of Anemia and Blood Pressure With Novel Markers of Diastolic Function in Pediatric Sickle Cell Disease.
     J Pediatr Hematol Oncol. 2021 Feb 22. pii: 00043426-900000000-96969.
     PubMed     Abstract available
     
     
     
115. AYDIN KOKER S, Caliskan Polat A
     Eltrombopag Add-on Treatment in a Child With Fanconi Aplastic Anemia Awaiting Hematopoietic Stem Cell Transplantation.
     J Pediatr Hematol Oncol. 2021 Feb 3. pii: 00043426-900000000-97003.
     PubMed     Abstract available
     
     
     
116. IDRIS IM, Bonnet K, Schlundt D, Abba A, et al
     Psychometric Impact of Priapism on Lives of Adolescents and Adults With Sickle Cell Anemia: A Sequential Independent Mixed-Methods Design.
     J Pediatr Hematol Oncol. 2021 Feb 3. pii: 00043426-900000000-96994.
     PubMed     Abstract available
     
     
     January 2021
117. SARBAY H, Atay A, Malbora B
     COVID-19 Infection in a Child With Thalassemia Major After Hematopoietic Stem Cell Transplant.
     J Pediatr Hematol Oncol. 2021;43:33-34.
     PubMed    
     
     
     
118. OYMAK Y, Karapinar TH, Devrim I
     Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
     J Pediatr Hematol Oncol. 2021;43:35-36.
     PubMed    
     
     
     
119. INGERSKI LM, Loew M, Porter JS, Su Y, et al
     Use of Wise Device Technology to Measure Adherence to Hydroxyurea Therapy in Youth With Sickle Cell Disease.
     J Pediatr Hematol Oncol. 2021;43:e19-e25.
     PubMed     Abstract available
     
     
     
120. CHAKRABORTY S, Dua V, Sachdev M, Bansal M, et al
     Horner Syndrome: An Unknown Entity After Tunneled Central Venous Catheter Insertion.
     J Pediatr Hematol Oncol. 2021;43:37-38.
     PubMed    
     
     
     
121. ZEKAVAT OR, Zareian Jahromi M, Haghpanah S, Kargar Jahromi Z, et al
     Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
     J Pediatr Hematol Oncol. 2021;43:e26-e28.
     PubMed     Abstract available
     
     
     
122. SAHIB S, Hanna M, Miller ST
     Nonsurgical Management of Acute Appendicitis in Sickle Cell Disease.
     J Pediatr Hematol Oncol. 2021;43:28-30.
     PubMed     Abstract available
     
     
     
123. REGLING K, Pomerantz D, Narayanan S, Altinok D, et al
     Reversible Cerebral Vasoconstriction Syndrome and Sickle Cell Disease: A Case Report.
     J Pediatr Hematol Oncol. 2021;43:e95-e98.
     PubMed     Abstract available
     
     
     
124. YILMAZ KESKIN E, Acar O, Ozbas H
     Missed Diagnosis of beta-Thalassemia Trait in Premarital Screening Due to Accompanying HbA2-Yialousa (HBD: c.82G>T).
     J Pediatr Hematol Oncol. 2021;43:e103-e104.
     PubMed     Abstract available
     
     
     December 2020
125. MOHSENY AB, Eikema DA, Neven B, Kroger N, et al
     Hematopoietic Stem Cell Transplantation for Hepatitis-associated Aplastic Anemia Following Liver Transplantation for Nonviral Hepatitis: A Retrospective Analysis and a Review of the Literature by the Severe Aplastic Anemia Working Party of the Europea
     J Pediatr Hematol Oncol. 2020 Dec 2. doi: 10.1097/MPH.0000000000001991.
     PubMed     Abstract available
     
     
     November 2020
126. FIELD MT, Chapple A, Hoeppner C, Boiko JR, et al
     Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia.
     J Pediatr Hematol Oncol. 2020 Nov 23. doi: 10.1097/MPH.0000000000002021.
     PubMed     Abstract available
     
     
     
127. NOISETTE ML, Phillips S, Schlenz AM, Mueller M, et al
     Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic.
     J Pediatr Hematol Oncol. 2020 Nov 23. doi: 10.1097/MPH.0000000000002008.
     PubMed     Abstract available
     
     
     
128. ABADESSO C, Pacheco S, Machado MC, Finley GA, et al
     Pain in Children and Adolescents With Sickle Cell Disease: Multidimensional Assessment.
     J Pediatr Hematol Oncol. 2020;42:455-462.
     PubMed     Abstract available
     
     
     
129. CALLAWAY D, Chawla A, Sprinz P
     Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers.
     J Pediatr Hematol Oncol. 2020;42:463-466.
     PubMed     Abstract available
     
     
     
130. SAHDEV I, Brochstein J, Werther N, Stiles J, et al
     Timing of Alemtuzumab With Respect to Day of Bone Marrow Infusion and its Effects Upon Engraftment and Graft-Versus-Host Disease in Patients With Sickle Cell Disease: A Single-Institutional Study.
     J Pediatr Hematol Oncol. 2020;42:e718-e722.
     PubMed     Abstract available
     
     
     
131. GOODE E, Boruchov D, Oliveira JL, Lau CC, et al
     Hemoglobin S/Hemoglobin Quebec-Chori Presenting as Sickle Cell Disease: A Case Report.
     J Pediatr Hematol Oncol. 2020;42:e775-e777.
     PubMed     Abstract available
     
     
     
132. SHAHEEN I, Khorshied M, Abdel-Raouf R, Gouda H, et al
     L-Selectin P213S and Integrin Alpha 2 C807T Genetic Polymorphisms in Pediatric Sickle Cell Disease Patients.
     J Pediatr Hematol Oncol. 2020;42:e707-e711.
     PubMed     Abstract available
     
     
     
133. THEODORIDOU S, Balassopoulou A, Boutou E, Delaki EE, et al
     Coinheritance of Triplicated Alpha-Globin Gene and Beta-Thalassemia Mutations in Adulthood: Ten Years of Referrals in Northern Greece.
     J Pediatr Hematol Oncol. 2020;42:e762-e764.
     PubMed     Abstract available
     
     
     
134. NAZIR HF, Alshizawi M
     Neutropenia and Life-threatening Agranulocytosis Among Children With beta-Thalassemia Treated With Oral Iron Chelators in a Community With Background of Ethnic Neutropenia.
     J Pediatr Hematol Oncol. 2020;42:e750-e755.
     PubMed     Abstract available
     
     
     October 2020
135. LUDLOW A, George N, Glassford M, Udenberg K, et al
     The Use of B-Cell Polysome Profiling to Validate Novel RPL5 (uL18) and RPL26 (uL24) Variants in Diamond-Blackfan Anemia.
     J Pediatr Hematol Oncol. 2020 Oct 28. doi: 10.1097/MPH.0000000000001980.
     PubMed     Abstract available
     
     
     
136. YILMAZ E, Kuehn HS, Odakir E, Niemela JE, et al
     Common Variable Immunodeficiency, Autoimmune Hemolytic Anemia, and Pancytopenia Associated With a Defect in IKAROS.
     J Pediatr Hematol Oncol. 2020 Oct 28. doi: 10.1097/MPH.0000000000001976.
     PubMed     Abstract available
     
     
     
137. SACHDEV M, Bansal M, Chakraborty S, Jain S, et al
     Allogeneic Hematopoietic Stem Cell Transplant Offer Good Outcomes in Pediatric Aplastic Anemia: Experience From Developing World.
     J Pediatr Hematol Oncol. 2020 Oct 28. doi: 10.1097/MPH.0000000000001981.
     PubMed     Abstract available
     
     
     
138. FALCON C, Hamm AJ, Li G, Lebensburger J, et al
     Novel CUBN Mutation in a Young Child With Megaloblastic Anemia.
     J Pediatr Hematol Oncol. 2020 Oct 7. doi: 10.1097/MPH.0000000000001958.
     PubMed     Abstract available
     
     
     
139. FASHAKIN V, Mathur S, Kwagala P, Mupere E, et al
     Parental Notification Via Text Messaging for Infant Sickle Screening Programs: Exploration of Feasibility and Acceptability in Uganda.
     J Pediatr Hematol Oncol. 2020;42:e593-e600.
     PubMed     Abstract available
     
     
     
140. ELCHURI SV, Williamson Lewis R, Quarmyne MO, Haight AE, et al
     Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.
     J Pediatr Hematol Oncol. 2020;42:e575-e582.
     PubMed     Abstract available
     
     
     
141. PANIZO MORGADO E, Darnaude MT, Torres Mohedas J, Benedit M, et al
     Beta-Spectrin Deletion Responsible for Hereditary Spherocytosis: When New Technologies Are Not the Key to Success.
     J Pediatr Hematol Oncol. 2020;42:e686-e688.
     PubMed     Abstract available
     
     
     
142. AGGARWAL P, Kumar I, Jain A, Verma A, et al
     Relation Between Cardiac T2* Values and Electrocardiographic Parameters in Children With Transfusion-dependent Thalassemia.
     J Pediatr Hematol Oncol. 2020;42:e610-e614.
     PubMed     Abstract available
     
     
     
143. ASLAN D
     Is Hemoglobin D Trait Hematologically Silent: Comparison With Healthy Controls and beta-thalassemia Carriers.
     J Pediatr Hematol Oncol. 2020;42:e698-e701.
     PubMed     Abstract available
     
     
     September 2020
144. YADAV SP, Thakkar D, Chatterjee G, Kapoor R, et al
     Upfront Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Children With Severe Aplastic Anemia.
     J Pediatr Hematol Oncol. 2020 Sep 29. doi: 10.1097/MPH.0000000000001957.
     PubMed    
     
     
     August 2020
145. MARTIN OY, Thompson SM, Carroll AE, Jacob SA, et al
     Emergency Department Provider Survey Regarding Acute Sickle Cell Pain Management.
     J Pediatr Hematol Oncol. 2020;42:375-380.
     PubMed     Abstract available
     
     
     
146. SHAHIDI M, Hashemi SR, Fattahi N, Roshani D, et al
     The Effects of L-Carnitine on Echocardiographic Changes in Patients With beta-Thalassemia Major and Intermedia.
     J Pediatr Hematol Oncol. 2020;42:386-390.
     PubMed     Abstract available
     
     
     
147. PINCEZ T, Ovetchkine P, Pastore Y
     Fusobacterium nucleatum Multiple Liver Abscesses in an Adolescent With Hemoglobin SC Disease.
     J Pediatr Hematol Oncol. 2020;42:410-411.
     PubMed     Abstract available
     
     
     
148. BROUSSEAU DC, Muslu CS, Visotcky A, Fraser R, et al
     Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care.
     J Pediatr Hematol Oncol. 2020;42:412-413.
     PubMed    
     
     
     
149. EL-SHANSHORY M, Tolba O, El-Shafiey R, Elgamasy M, et al
     Cardiac Iron Overload by MRI in Children With B-Thalassemia Major and its Correlation With Cardiac Function by Echocardiography.
     J Pediatr Hematol Oncol. 2020;42:398-402.
     PubMed     Abstract available
     
     
     
150. KOTHIMIRA VK, Kumar A, Richhele LR, Sood N, et al
     An Evaluation of Bone Health Parameters in Regularly Transfused Beta-Thalassemia Major Patients.
     J Pediatr Hematol Oncol. 2020;42:381-385.
     PubMed     Abstract available
     
     
     
151. QURESHI TN, Haider SR, Al Rawas A, Al Sukaiti R, et al
     Pulmonary Artery Pseudoaneurysm in a Child With beta-Thalassemia Major.
     J Pediatr Hematol Oncol. 2020;42:e503-e506.
     PubMed     Abstract available
     
     
     
152. RATHNAYAKE D, Somasuriyan K, Kumarasamy Thadsanamoorthy S, Maheshvaran U, et al
     Klebsiella pneumoniae Multiple Liver Abscesses and Bacteremia in a Transfusion-dependent beta Thalassemia Major Patient.
     J Pediatr Hematol Oncol. 2020;42:e497-e498.
     PubMed     Abstract available
     
     
     
153. GURUNATHAN A, Tarango C, McGann PT, Niss O, et al
     Non-transfusion-dependent beta-Thalassemia Because of a Single beta-Thalassemia Mutation and Coinherited alpha-Globin Gene Triplication: Need for Increased Awareness to Prevent Incorrect and Delayed Diagnosis.
     J Pediatr Hematol Oncol. 2020;42:e494-e496.
     PubMed     Abstract available
     
     
     July 2020
154. EBEID FSE, Khan NIH
     The Adverse Impact of Thalassemia Major on Adolescents' Oral Health-related Quality of Life.
     J Pediatr Hematol Oncol. 2020;42:e345-e351.
     PubMed     Abstract available
     
     
     
155. RAMPHUL K, Mejias SG, Joynauth J
     Patients With Sickle Cell Disease Between Ages 0 and 20 Years Presenting With Acute Chest Syndrome in the United States.
     J Pediatr Hematol Oncol. 2020;42:367-368.
     PubMed    
     
     
     
156. ELALFY MS, Ebeid FSE, El Gendy YG, Zaki MM, et al
     Body Composition in Egyptian Children With Transfusion-dependent Thalassemia: The Impact of Nutrition and Metabolic Profile.
     J Pediatr Hematol Oncol. 2020;42:e334-e339.
     PubMed     Abstract available
     
     
     
157. KREPIS P, Maritsi DN, Tsolia MN, Vakaki M, et al
     Massive Splenic Infarction and Autosplencetomy: First Presentation of Homozygous Sickle Cell Disease in a Toddler.
     J Pediatr Hematol Oncol. 2020;42:371-372.
     PubMed    
     
     
     
158. SCHLAPPI C, Bernstock JD, Ricketts W, Nix GA, et al
     Roseomonas gilardii Bacteremia in a Patient With HbSbeta0-thalassemia: Clinical Implications and Literature Review.
     J Pediatr Hematol Oncol. 2020;42:e385-e387.
     PubMed     Abstract available
     
     
     May 2020
159. OZDEMIR ZC, Kar YD, Gunduz E, Bor O, et al
     Evaluation of the Coagulation Profile With Rotational Thromboelastometry in Children With Hereditary Spherocytosis.
     J Pediatr Hematol Oncol. 2020;42:e195-e198.
     PubMed     Abstract available
     
     
     
160. MOSKOP A, Dalrymple A, Dolatshahi L
     Systemic Lupus Erythematosus, Evans Syndrome, and Neurofibromatosis: An Unusual Combination in Pediatric Patient.
     J Pediatr Hematol Oncol. 2020;42:e244-e247.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: